Our viral RT-PCR test was authorized under FDA (EUA) with a proven accuracy rate of 99.9% to diagnose an active COVID-19 infection
The Centers for Disease Control and Prevention (CDC) protects the United States
from health, safety and security threats, both in and outside of the U.S.
SDI Labs’ COVID-19 Viral RT-PCR RNA test has not been FDA cleared or approved. It has been authorized
by FDA under an Emergency Use Authorization (EUA), and has been authorized only for the detection of
nucleic acid from SARS-CoV-2, not for any other viruses or pathogens.
The Clinical Laboratory Improvement Amendments (CLIA) ensure quality laboratory testing and upholds
industry standards. SDI Labs is CLIA certified.
The Health Insurance Portability and Accountability Act (HIPAA) ensures that a patient’s medical
information is kept safe. SDI Labs is HIPAA compliant.
SDI LABS’ COVID-19 TESTING FOR QUALITY PATIENT CARE
Our viral RT-PCR test and antibody test were authorized under FDA (EUA) on March 31st, 2020
OUR INSURANCE PARTNERS
Our clients include Federal, State and Private Insurance groups such has Anthem Blue, Humana,
Blue Cross Blue Shields of California and many other national level plans
OUR ACCREDITATIONS and CERTIFICATIONS
Our accreditation include groups such as FDA, CLIA, and CAP